Related Experiment Video
Updated: Feb 17, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
Long non-coding RNA GAS5 suppresses pancreatic cancer metastasis through modulating miR-32-5p/PTEN axis
Zhi-Qiang Gao1, Jun-Feng Wang1, De-Hua Chen1
1Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, Henan People's Republic of China.
Background:
Long non-coding RNA growth arrest-specific transcript 5 (lncRNA GAS5) is a well-known tumor suppressor in the pathogenesis of a variety of human cancers. The precise role of GAS5 in pancreatic cancer (PC) progression is currently unknown, so the aim of this study was to explore the functional participation of GAS5 in PC metastasis.
Methods:
The expression changes of GAS5, miR-32-5p and PTEN in human PC specimens and cell lines were compared by means of molecular biology methods. Transfection of the recombinant plasmid was applied to modulate the expression levels of the target genes. RIP and RNA pull-down assays were designed to investigate the interaction between GAS5 and miR-32-5p. The effect of GAS5 and miR-32-5p on PC progression was assessed with cell proliferation, migration, invasion and apoptosis in vitro.
Results:
GAS5 and PTEN protein were decreased in human PC tissues and cells, but miR-32-5p was increased. GAS5 induction greatly inhibited the proliferation, migration and invasion of PC cells PANC-1 and BxPC-3 in vitro and simultaneously induced cell apoptosis. Moreover, GAS5 positively regulated the expression of PTEN through miR-32-5p. Furthermore, GAS5 suppressed the proliferation, migration and invasion of PC cells through regulating miR-32-5p/PTEN axis. Additionally, this finding was further supported by the results of in vivo experiments.
Conclusion:
GAS5 could positively regulate PTEN-induced tumor-suppressor pathway via miR-32-5p, thereby suppressing PC metastasis.
Insights
Long non-coding RNA GAS5 suppresses pancreatic cancer metastasis by regulating the miR-32-5p/PTEN axis. This finding reveals GAS5 as a potential therapeutic target for inhibiting pancreatic cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNA growth arrest-specific transcript 5 (lncRNA GAS5) is recognized as a tumor suppressor in various human cancers.
- The specific role of GAS5 in pancreatic cancer (PC) progression and metastasis remains largely uncharacterized.
Purpose of the Study:
- To investigate the functional role of lncRNA GAS5 in pancreatic cancer metastasis.
- To elucidate the molecular mechanism underlying GAS5's function in PC progression.
Main Methods:
- Comparative analysis of GAS5, miR-32-5p, and PTEN expression in PC tissues and cell lines.
- In vitro and in vivo experiments assessing cell proliferation, migration, invasion, and apoptosis following GAS5 modulation.
- RNA immunoprecipitation (RIP) and RNA pull-down assays to confirm GAS5-miR-32-5p interaction.
Main Results:
- GAS5 and PTEN expression were downregulated, while miR-32-5p was upregulated in PC tissues and cells.
- GAS5 induction inhibited PC cell proliferation, migration, and invasion, while promoting apoptosis.
- GAS5 positively regulated PTEN expression via miR-32-5p, suppressing PC cell progression through the miR-32-5p/PTEN axis.
Conclusions:
- GAS5 acts as a tumor suppressor in pancreatic cancer by positively regulating the PTEN-induced tumor-suppressor pathway through miR-32-5p.
- GAS5 effectively suppresses pancreatic cancer metastasis, highlighting its potential as a therapeutic target.
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Non-Canonical Wnt Signaling Pathways
mTOR Signaling and Cancer Progression
The mTOR pathway or the...